Package Leaflet: Information for the User
Rivaroxaban Dr. Reddys 15 mg film-coated tablets EFG
Rivaroxaban Dr. Reddys 20 mg film-coated tablets EFG
rivaroxaban
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Rivaroxaban Dr. Reddys contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban Dr. Reddys is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:
Rivaroxaban Dr. Reddys belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Dr. Reddys
Do not take Rivaroxaban Dr. Reddys and inform your doctorif any of these conditions apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting Rivaroxaban Dr. Reddys.
Be careful with Rivaroxaban Dr. Reddys
Tell your doctor if you have any of these conditionsbefore taking Rivaroxaban Dr. Reddys. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need surgery
Children and adolescents
Rivaroxaban Dr. Reddys is not recommended in children with a body weight below 30 kg.There is not enough information about the use of rivaroxaban in children and adolescents for the indications in adults.
Other medicines and Rivaroxaban Dr. Reddys
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.
If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may increase. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, he/she will recommend that you also use a treatment to prevent ulcers.
If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of Rivaroxaban Dr. Reddys may be reduced. Your doctor will decide if you should be treated with Rivaroxaban Dr. Reddys and if you should be kept under closer observation.
Pregnancy and breast-feeding
Do not take rivaroxaban if you are pregnant or breast-feeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.
Rivaroxaban Dr. Reddys contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult him/her before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
This medicine should be taken with food.
Swallow the tablet, preferably with water.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple puree, immediately before taking it.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
What dose to take
Adults
The recommended dose is one rivaroxaban 20 mg tablet once a day.
If you have kidney problems, the dose may be reduced to one rivaroxaban 15 mg tablet once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent insertion), there is limited evidence to reduce the dose to one rivaroxaban 15 mg tablet once a day (or to one rivaroxaban 10 mg tablet once a day in case of impaired kidney function) in addition to an antiplatelet medicine such as clopidogrel.
The recommended dose is one rivaroxaban 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one Rivaroxaban 20 mg tablet once a day.
After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one 10 mg tablet once a day or one 20 mg tablet once a day.
If you have kidney problems and are taking one Rivaroxaban 20 mg tablet once a day, your doctor may decide to reduce the treatment dose to one Rivaroxaban 15 mg tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
Children and adolescents
The dose of rivaroxaban depends on body weight and will be calculated by the doctor.
Take each dose of rivaroxaban with a drink (e.g. water or juice) during a meal. Take the tablets every day at approximately the same time. Consider setting an alarm to remind you. For parents or caregivers: observe the child to ensure they take the full dose.
As the dose of rivaroxaban is based on body weight, it is important to attend scheduled medical visits because it may be necessary to adjust the dose as weight changes.
Never adjust the dose of rivaroxaban yourself. The doctor will adjust the dose if necessary.
Do not divide the tablet in an attempt to provide a fraction of the dose of a tablet. If a lower dose is required, use the alternative presentation of rivaroxaban granules for oral suspension. In the case of children and adolescents who cannot swallow whole tablets, use rivaroxaban granules for oral suspension.
If the oral suspension is not available, you can crush the rivaroxaban tablet and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
If you spit out the dose or vomit
Contact your doctor if you spit out the dose or vomit repeatedly after taking rivaroxaban.
When to take Rivaroxaban Dr. Reddys
Take the tablet every day, until your doctor tells you to stop.
Try to take a tablet at the same time every day, to help you remember. The doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the brain (stroke) or in other blood vessels:
If it is necessary to normalize your heartbeat through a procedure called cardioversion, take rivaroxaban at the time indicated by your doctor.
If you forget to take Rivaroxaban Dr. Reddys
Adults, children and adolescents:
Adults:
If you take more Rivaroxaban Dr. Reddys than you should
Contact your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
If you stop taking Rivaroxaban Dr. Reddys
Do not stop taking rivaroxaban without talking to your doctor first, because rivaroxaban prevents the development of a serious condition.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Like other similar medicines, to reduce the formation of blood clots, rivaroxaban can cause bleeding, which can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Tell your doctor immediatelyif you or the child suffer from any of the following adverse effects:
Signs of bleeding
A serious medical emergency. Seek medical attention immediately!
Your doctor will decide to keep you under closer observation or modify your treatment.
Signs of severe skin reaction:
Reactions
Signs of severe allergic reaction:
The frequencies of these adverse effects are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects found in adults, children, and adolescents
Frequent(may affect up to 1 in 10 patients)
Uncommon(may affect up to 1 in 100 patients)
Rare(may affect up to 1 in 1,000 patients)
Frequency not known(cannot be estimated from available data)
Adverse effects in children and adolescents
In general, the adverse effects observed in children and adolescents treated with rivaroxaban were similar to those observed in adults and were mainly of mild to moderate severity.
Adverse effects that were more frequently observed in children and adolescents:
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Very rare(may affect up to 1 in 10,000 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging and on each blister or bottle after "CAD" or "EXP". The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Rivaroxaban Dr. Reddys
Core of the tablet: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, hypromellose, sodium lauryl sulfate, magnesium stearate. See section 2 "Rivaroxaban Dr. Reddys contains lactose and sodium"
Coating of the tablet: macrogol 3350, hypromellose, titanium dioxide (E 171), yellow iron oxide (E 172).
Appearance of the product and package contents
15 mg
They are red, round, biconvex (approximately 6 mm in diameter) and have a "15" engraved on one side.
They are packaged in blisters, in boxes of 10, 14, 28, 42, 98, or 100 film-coated tablets
20 mg
They are dark red, round, biconvex (approximately 6 mm in diameter) and have a "20" engraved on one side.
They are packaged in blisters, in boxes of 10, 14, 28, 42, 98, or 100 film-coated tablets
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Reddy Pharma Iberia, S.A.
Avda. Josep Tarradellas nº 38
08029 Barcelona (Spain)
Phone: 93.355.49.16
Fax: 93.355.49.61
Manufacturer
Betapharm Arzneimittel GmbH
Kobelweg 95
86156 Augsburg
Germany
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany: | Rivaroxaban beta 15 mg Filmtabletten Rivaroxaban beta 20 mg Filmtabletten | Betapharm Arzneimittel GmbH |
Spain: | Rivaroxaban Dr. Reddys 15 mg film-coated tablets EFG Rivaroxaban Dr. Reddys 20 mg film-coated tablets EFG | Reddy Pharma Iberia, S.A. |
United Kingdom: | Rivaroxaban Dr. Reddy’s 15 mg Film-Coated Tablets Rivaroxaban Dr. Reddy’s 20 mg Film-Coated Tablets | Dr. Reddy’s Laboratories (UK) Ltd. |
Italy: | RIVAROXABAN DR. REDDY’S 15 mg film-coated tablets RIVAROXABAN DR. REDDY’S 20 mg film-coated tablets | Dr. Reddy’s S.r.l. Italy |
Date of the last revision of this leaflet:September 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)